The NFIB mRNA expression level was significantly decreased in seven unique analyses, across different lung cancer subtypes, in five different databases including Stearman (Stearman et al., 2005), Bhattacharjee (Bhattacharjee et al., 2001), Garber (Garber et al., 2001), Wachi and Hou (Hou et al., 2010; Wachi, Yoneda & Wu, 2005). The gene discussed is NFIB; the disease is lung carcinoma.